Stock Track | Avalyn Pharma Soars 44.44% in Intraday Trading on Nasdaq IPO Debut

Stock Track

May 01

Avalyn Pharma's stock soared 44.44% in intraday trading on Thursday as the clinical-stage biopharmaceutical company made its trading debut on the Nasdaq Global Select Market.

The company's upsized initial public offering was priced at $18 per share, at the top end of the expected $16 to $18 range, raising $300 million. Avalyn increased the offering size from 11.8 million to 16.7 million shares, indicating strong investor demand for the IPO.

Proceeds from the offering will fund late-stage clinical studies for Avalyn's pipeline of inhaled therapeutics for rare respiratory diseases, including its lead candidates AP01 and AP02. The company's successful IPO pricing and trading debut reflect investor confidence in its clinical programs and market potential.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1133662273"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133662273\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133662273?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-01 01:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133662273","market":"us","top_or_hot":-1,"title":"Stock Track | Avalyn Pharma Soars 44.44% in Intraday Trading on Nasdaq IPO Debut","media":"Stock Track","content":"<p>Avalyn Pharma's stock soared 44.44% in intraday trading on Thursday as the clinical-stage biopharmaceutical company made its trading debut on the Nasdaq Global Select Market.</p><p>The company's upsized initial public offering was priced at $18 per share, at the top end of the expected $16 to $18 range, raising $300 million. Avalyn increased the offering size from 11.8 million to 16.7 million shares, indicating strong investor demand for the IPO.</p><p>Proceeds from the offering will fund late-stage clinical studies for Avalyn's pipeline of inhaled therapeutics for rare respiratory diseases, including its lead candidates AP01 and AP02. The company's successful IPO pricing and trading debut reflect investor confidence in its clinical programs and market potential.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Avalyn Pharma Soars 44.44% in Intraday Trading on Nasdaq IPO Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Avalyn Pharma Soars 44.44% in Intraday Trading on Nasdaq IPO Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-01 01:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Avalyn Pharma's stock soared 44.44% in intraday trading on Thursday as the clinical-stage biopharmaceutical company made its trading debut on the Nasdaq Global Select Market.</p><p>The company's upsized initial public offering was priced at $18 per share, at the top end of the expected $16 to $18 range, raising $300 million. Avalyn increased the offering size from 11.8 million to 16.7 million shares, indicating strong investor demand for the IPO.</p><p>Proceeds from the offering will fund late-stage clinical studies for Avalyn's pipeline of inhaled therapeutics for rare respiratory diseases, including its lead candidates AP01 and AP02. The company's successful IPO pricing and trading debut reflect investor confidence in its clinical programs and market potential.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVLN","symbol_name":"Avalyn Pharma","start_time":0,"source_url":"","article_id":"1133662273","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133662273","pubTimestamp":1777570002,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Avalyn Pharma's stock soared 44.44% in intraday trading on Thursday as the clinical-stage biopharmaceutical company made its trading debut on the Nasdaq Global Select Market.The company's upsized...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AVLN":"Avalyn Pharma"},"translate_title":"股票追踪|Avalyn Pharma纳斯达克IPO首秀盘中大涨44.44%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVLN":1},"content_text":"Avalyn Pharma's stock soared 44.44% in intraday trading on Thursday as the clinical-stage biopharmaceutical company made its trading debut on the Nasdaq Global Select Market.The company's upsized initial public offering was priced at $18 per share, at the top end of the expected $16 to $18 range, raising $300 million. Avalyn increased the offering size from 11.8 million to 16.7 million shares, indicating strong investor demand for the IPO.Proceeds from the offering will fund late-stage clinical studies for Avalyn's pipeline of inhaled therapeutics for rare respiratory diseases, including its lead candidates AP01 and AP02. The company's successful IPO pricing and trading debut reflect investor confidence in its clinical programs and market potential.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}